Few Smad proteins and many Smad-interacting proteins yield multiple functions and action modes in TGFβ/BMP signaling in vivo

Cytokine and Growth Factor Reviews

Volumn 22, Issue 5-6, 2011, Pages 287-300

  Conidi, Andrea ^a   Cazzola, Silvia ^a   Beets, Karen ^a,b   Coddens, Kathleen ^a   Collart, Clara ^a,c   Cornelis, Frederique ^a,b   Cox, Luk ^a,b   Joke, Debruyn ^a   Dobreva, Mariya P ^a,b   Dries, Ruben ^a   Esguerra, Camila ^a   Francis, Annick ^a   Ibrahimi, Abdelilah ^a   Kroes, Roel ^a   Lesage, Flore ^a   Maas, Elke ^a,b   Moya, Ivan ^a,b   Pereira, Paulo N G ^a,b   Stappers, Elke ^a   Stryjewska, Agata ^a   van den Berghe, Veronique ^a   Vermeire, Liesbeth ^a,d   Verstappen, Griet ^a   Seuntjens, Eve ^a   Umans, Lieve ^a,b   Zwijsen, An ^a,b   Huylebroeck, Danny ^a   more..

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Department of Molecular and Developmental Genetics ^*  (Belgium)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d InfraMouse Animal facility   (Belgium)

Author keywords

CPSF; Sip1; Smad; Tdp2; Transforming growth factor

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CELL PROTEIN; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; SMAD PROTEIN; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

BINDING AFFINITY; BINDING SITE; CELL CULTURE; CELL TYPE; CONFORMATIONAL TRANSITION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SUBUNIT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; HUMANS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

VERTEBRATA;

EID: 82955203433     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2011.11.006     Document Type: Review

References (151)

1. Feng X.H., Derynck R. Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 2005, 21:659-693.
2. Schmierer B., Hill C.S. TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 2007, 8:970-982.
3. Derynck R., Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signaling. Nature 2003, 425:577-584.
4. Itoh S., ten Dijke P. Negative regulation of TGF-beta receptor/Smad signal transduction. Curr Opin Cell Biol 2007, 19:176-184.
5. Moustakas A., Heldin C.H. The regulation of TGFbeta signal transduction. Development 2009, 136:3699-3714.
6. David L., Mallet C., Mazerbourg S., Feige J.J., Bailly S. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 2007, 109:1953-1961.
7. David L., Mallet C., Keramidas M., Lamandé N., Gasc J.M., Dupuis-Girod S., et al. Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res 2008, 102:914-922.
8. Goumans M.J., Liu Z., ten Dijke P. TGF-beta signaling in vascular biology and dysfunction. Cell Res 2009, 19:116-127.
9. David L., Feige J.J., Bailly S. Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 2009, 20:203-212.
10. Pardali E., Goumans M.J., ten Dijke P. Signaling by members of the TGF-beta family in vascular morphogenesis and disease. Trends Cell Biol 2010, 20:556-567.
11. Le Roy C., Wrana J.L. Clathrin- and non-clathrin-mediated endocytic regulation of cell signaling. Nat Rev Mol Cell Biol 2005, 6:112-126.
12. Hartung A., Bitton-Worms K., Rechtman M.M., Wenzel V., Boergermann J.H., Hassel S., et al. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Mol Cell Biol 2006, 26:7791-7805.
13. Sieber C., Kopf J., Hiepen C., Knaus P. Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev 2009, 20:343-355.
14. Nickel J., Sebald W., Groppe J.C., Mueller T.D. Intricacies of BMP receptor assembly. Cytokine Growth Factor Rev 2009, 20:367-377.
15. Zawel L., Dai J.L., Buckhaults P., Zhou S., Kinzler K.W., Vogelstein B., et al. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1998, 1:611-617.
16. Dennler S., Itoh S., Vivien D., ten Dijke P., Huet S., Gauthier J.M. Direct binding of Smad3 and Smad4 to critical TGFbeta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 1998, 17:3091-3100.
17. Ishida W., Hamamoto T., Kusanagi K., Yagi K., Kawabata M., Takehara K., et al. Characterization of bone morpho-genetic protein-responsive element in the mouse Smad6 promoter. J Biol Chem 2000, 275:6075-6079.
18. López-Rovira T., Chalaux E., Massagué J., Rosa J.L., Ventura F. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein-specific transcriptional activation of Id1 gene. J Biol Chem 2002, 277:3176-3185.
19. Brugger S.M., Merrill A.E., Torres-Vazquez J., Wu N., Ting M.C., Cho J.Y., et al. A phylogenetically conserved cis-regulatory module in the Msx2 promoter is sufficient for BMP-dependent transcription in murine and Drosophila embryos. Development 2004, 131:5153-5165.
20. Korchynskyi O., ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 2002, 277:4883-4891.
21. Nishihara A., Hanai J.I., Okamoto N., Yanagisawa J., Kato S., Miyazono K., et al. Role of p300, a transcriptional coactivator, in signaling of TGF-beta. Genes Cells 1998, 3:613-623.
22. Pearson K.L., Hunter T., Janknecht R. Activation of Smad1-mediated transcription by p300/CBP. Biochim Biophys Acta 1999, 1489:354-364.
23. Attisano L., Wrana J.L. Smads as transcriptional co-modulators. Curr Opin Cell Biol 2000, 12:235-243.
24. Corradini E., Babitt J.L., Lin H.Y. The RGM/DRAGON family of BMP co-receptors. Cytokine Growth Factor Rev 2009, 20:389-398.
25. Kang J.S., Liu C., Derynck R. New regulatory mechanisms of TGF-beta receptor function. Trends Cell Biol 2009, 19:385-394.
26. Zakin L., De Robertis E.M. Extracellular regulation of BMP signaling. Curr Biol 2010, 20:R89-R92.
27. Hill C.S. Nucleocytoplasmic shuttling of Smad proteins. Cell Res 2009, 19:36-46.
28. Ishimura A., Ng J.K., Taira M., Young S.G., Osada S. Man1, an inner nuclear membrane protein, regulates vascular remodeling by modulating transforming growth factor beta signaling. Development 2006, 133:3919-3928.
29. Hellemans J., Preobrazhenska O., Willaert A., Debeer P., Verdonk P.C., Costa T., et al. Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis. Nat Genet 2004, 36:1213-1218.
30. Davis B.N., Hilyard A.C., Lagna G., Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008, 454:56-61.
31. Zhang H., Bradley A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 1996, 122:2977-2986.
32. Winnier G., Blessing M., Labosky P.A., Hogan B.L. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 1995, 9:2105-2116.
33. Lawson K.A., Dunn N.R., Roelen B.A., Zeinstra L.M., Davis A.M., Wright C.V., et al. Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes Dev 1999, 13:424-436.
34. Mishina Y., Suzuki A., Ueno N., Behringer R.R. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 1995, 9:3027-3037.
35. Beppu H., Kawabata M., Hamamoto T., Chytil A., Minowa O., Noda T., et al. BMP type II receptor is required for gastrulation and early development of mouse embryos. Dev Biol 2000, 221:249-258.
36. Arnold S.J., Maretto S., Islam A., Bikoff E.K., Robertson E.J. Dose-dependent Smad1, Smad5 and Smad8 signaling in the early mouse embryo. Dev Biol 2006, 296:104-118.
37. Chang H., Huylebroeck D., Verschueren K., Guo Q., Matzuk M.M., Zwijsen A. Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development 1999, 126:1631-1642.
38. Yang X., Castilla L.H., Xu X., Li C., Gotay J., Weinstein M., et al. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development 1999, 126:1571-1580.
39. Umans L., Cox L., Tjwa M., Bito V., Vermeire L., Laperre K., et al. Inactivation of Smad5 in endothelial cells and smooth muscle cells demonstrates that Smad5 is required for cardiac homeostasis. Am J Pathol 2007, 170:1460-1472.
40. Tremblay K.D., Dunn N.R., Robertson E.J. Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development 2001, 128:3609-3621.
41. Lechleider R.J., Ryan J.L., Garrett L., Eng C., Deng C., Wynshaw-Boris A., et al. Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion. Dev Biol 2001, 240:157-167.
42. Hayashi K., Kobayashi T., Umino T., Goitsuka R., Matsui Y., Kitamura D. SMAD1 signaling is critical for initial commitment of germ cell lineage from mouse epiblast. Mech Dev 2002, 118:99-109.
43. Furtado M.B., Solloway M.J., Jones V.J., Costa M.W., Biben C., Wolstein O., et al. BMP/SMAD1 signaling sets a threshold for the left/right pathway in lateral plate mesoderm and limits availability of SMAD4. Genes Dev 2008, 22:3037-3049.
44. Bosman E.A., Lawson K.A., Debruyn J., Beek L., Francis A., Schoonjans L., et al. Smad5 determines murine amnion fate through the control of bone morphogenetic protein expression and signaling levels. Development 2006, 133:3399-3409.
45. Ben-Haim N., Lu C., Guzman-Ayala M., Pescatore L., Mesnard D., Bischofberger M., et al. The nodal precursor acting via activin receptors induces mesoderm by maintaining a source of its convertases and BMP4. Dev Cell 2006, 11:313-323.
46. Shen M.M. Nodal signaling: developmental roles and regulation. Development 2007, 134:1023-1034.
47. Daly A.C., Randall R.A., Hill C.S. Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol Cell Biol 2008, 28:6889-6902.
48. Kaplan F.S., Xu M., Seemann P., Connor J.M., Glaser D.L., Carroll L., et al. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat 2009, 30:379-390.
49. Groppe J.C., Wu J., Shore E.M., Kaplan F.S. In vitro analyses of the dysregulated R206H ALK2 kinase-FKBP12 interaction associated with heterotopic ossification in FOP. Cells Tissues Organs 2011, 194:291-295.
50. Shen Q., Little S.C., Xu M., Haupt J., Ast C., Katagiri T., et al. The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. J Clin Invest 2009, 119:3462-3472.
51. Kaplan F.S., Pignolo R.J., Shore E.M. The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling. Cytokine Growth Factor Rev 2009, 20:399-407.
52. Yu P.B., Deng D.Y., Beppu H., Hong C.C., Lai C., Hoyng S.A., et al. Bone morphogenetic protein (BMP) type II receptor is required for BMP-mediated growth arrest and differentiation in pulmonary artery smooth muscle cells. J Biol Chem 2008, 283:3877-3888.
53. Lebrin F., Mummery C.L. Endoglin-mediated vascular remodeling: mechanisms underlying hereditary hemorrhagic telangiectasia. Trends Cardiovasc Med 2008, 18:25-32.
54. Shovlin C.L. Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev 2010, 24:203-219.
55. Lowery J.W., de Caestecker M.P. BMP signaling in vascular development and disease. Cytokine Growth Factor Rev 2010, 21:287-298.
56. Cunha S.I., Pietras K. ALK1 as an emerging target for antiangiogenic therapy of cancer. Blood 2011, 117:6999-7006.
57. Singh A., Morris R.J. The Yin and Yang of bone morphogenetic proteins in cancer. Cytokine Growth Factor Rev 2010, 21:299-313.
58. van Wijk B., Moorman A.F., van den Hoff M.J. Role of bone morphogenetic proteins in cardiac differentiation. Cardiovasc Res 2007, 74:244-255.
59. Boström K.I., Rajamannan N.M., Towler D.A. The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ Res 2011, 109:564-577.
60. Singh R., Kispert A. Tbx20, Smads, and the atrioventricular canal. Trends Cardiovasc Med 2010, 20:109-114.
61. Colak D., Mori T., Brill M.S., Pfeifer A., Falk S., Deng C., et al. Adult neurogenesis requires Smad4-mediated bone morphogenic protein signaling in stem cells. J Neurosci 2008, 28:434-446.
62. Mira H., Andreu Z., Suh H., Lie D.C., Jessberger S., Consiglio A., et al. Signaling through BMPR-IA regulates quiescence and long-term activity of neural stem cells in the adult hippocampus. Cell Stem Cell 2010, 7:78-89.
63. Sabo J.K., Kilpatrick T.J., Cate H.S. Effects of bone morphogenic proteins on neural precursor cells and regulation during central nervous system injury. Neurosignals 2009, 17:255-264.
64. Robel S., Berninger B., Götz M. The stem cell potential of glia: lessons from reactive gliosis. Nat Rev Neurosci 2011, 12:88-104.
65. Li H., He Y., Richardson W.D., Casaccia P. Two-tier transcriptional control of oligodendrocyte differentiation. Curr Opin Neurobiol 2009, 19:479-485.
66. Emery B. Regulation of oligodendrocyte differentiation and myelination. Science 2010, 330:779-782.
67. Dummula K., Vinukonda G., Chu P., Xing Y., Hu F., Mailk S., et al. Bone morphogenetic protein inhibition promotes neurological recovery after intraventricular hemorrhage. J Neurosci 2011, 31:12068-12082.
68. Ono Y., Calhabeu F., Morgan J.E., Katagiri T., Amthor H., Zammit P.S. BMP signaling permits population expansion by preventing premature myogenic differentiation in muscle satellite cells. Cell Death Differ 2011, 18:222-234.
69. Daughters R.S., Chen Y., Slack J.M. Origin of muscle satellite cells in the Xenopus embryo. Development 2011, 138:821-830.
70. Friedrichs M., Wirsdöerfer F., Flohé S.B., Schneider S., Wuelling M., Vortkamp A. BMP signaling balances proliferation and differentiation of muscle satellite cell descendants. BMC Cell Biol 2011, 12:26.
71. Pangas S.A., Li X., Umans L., Zwijsen A., Huylebroeck D., Gutierrez C., et al. Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice. Mol Cell Biol 2008, 28:248-257.
72. Middlebrook B.S., Eldin K., Li X., Shivasankaran S., Pangas S.A. Smad1-Smad5 ovarian conditional knockout mice develop a disease profile similar to the juvenile form of human granulosa cell tumors. Endocrinology 2009, 150:5208-5217.
73. Nasim M.T., Ogo T., Ahmed M., Randall R., Chowdhury H.M., Snape K.M., et al. Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension. Hum Mutat 2011, [Epub ahead of print].
74. Burton V.J., Ciuclan L.I., Holmes A.M., Rodman D.M., Walker C., Budd D.C. Bone morphogenetic protein receptor II regulates pulmonary artery endothelial cell barrier function. Blood 2011, 117:333-341.
75. Morrell N.W. Role of bone morphogenetic protein receptors in the development of pulmonary arterial hypertension. Adv Exp Med Biol 2010, 661:251-264.
76. Dunn N.R., Vincent S.D., Oxburgh L., Robertson E.J., Bikoff E.K. Combinatorial activities of Smad2 and Smad3 regulate mesoderm formation and patterning in the mouse embryo. Development 2004, 131:1717-1728.
77. Hellström M., Phng L.K., Hofmann J.J., Wallgard E., Coultas L., Lindblom P., et al. Dll4 signaling through Notch1 regulates formation of tip cells during angiogenesis. Nature 2007, 445:776-780.
78. Orvis G.D., Jamin S.P., Kwan K.M., Mishina Y., Kaartinen V.M., Huang S., et al. Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse. Biol Reprod 2008, 78:994-1001.
79. Orvis G.D., Behringer R.R. Cellular mechanisms of Müllerian duct formation in the mouse. Dev Biol 2007, 306:493-504.
80. Josso N., Belville C., di Clemente N., Picard J.Y. AMH and AMH receptor defects in persistent Müllerian duct syndrome. Hum Reprod Update 2005, 11:351-356.
81. Behringer R.R., Finegold M.J., Cate R.L. Mullerian-inhibiting substance function during mammalian sexual development. Cell 1994, 79:415-425.
82. Mishina Y., Whitworth D.J., Racine C., Behringer R.R. High specificity of Mullerian-inhibiting substance signaling in vivo. Endocrinology 1999, 140:2084-2088.
83. Mishina Y., Rey R., Finegold M.J., Matzuk M.M., Josso N., Cate R.L., et al. Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev 1996, 10:2577-2587.
84. Jamin S.P., Arango N.A., Mishina Y., Hanks M.C., Behringer R.R. Requirement of Bmpr1a for Mullerian duct regression during male sexual development. Nat Genet 2002, 32:408-410.
85. Gaussin V., Van de Putte T., Mishina Y., Hanks M.C., Zwijsen A., Huylebroeck D., et al. Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3. Proc Natl Acad Sci USA 2002, 99:2878-2883.
86. Schneider M.D., Gaussin V., Lyons K.M. Tempting fate: BMP signals for cardiac morphogenesis. Cytokine Growth Factor Rev 2003, 14:1-4.
87. Collart C., Remacle J.E., Barabino S., van Grunsven L.A., Nelles L., Schellens A., et al. Smicl is a novel Smad interacting protein and cleavage and polyadenylation specificity factor associated protein. Genes Cells 2005, 10:897-906.
88. Millevoi S., Vagner S. Molecular mechanisms of eukaryotic pre-mRNA 3' end processing regulation. Nucleic Acids Res 2010, 38:2757-2774.
89. Collart C., Verschueren K., Rana A., Smith J.C., Huylebroeck D. The novel Smad-interacting protein Smicl regulates Chordin expression in the Xenopus embryo. Development 2005, 132:4575-4586.
90. Collart C., Ramis J.M., Down T.A., Smith J.C. Smicl is required for phosphorylation of RNA polymerase II and affects 3'-end processing of RNA at the midblastula transition in Xenopus. Development 2009, 136:3451-3461.
91. Pype S., Declercq W., Ibrahimi A., Michiels C., Van Rietschoten J.G., Dewulf N., et al. TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation. J Biol Chem 2000, 275:18586-18593.
92. Esguerra C.V., Nelles L., Vermeire L., Ibrahimi A., Crawford A.D., Derua R., et al. Ttrap is an essential modulator of Smad3-dependent Nodal signaling during zebrafish gastrulation and left-right axis determination. Development 2007, 134:4381-4393.
93. 2+-dependent neutral sphingomyelinase. Proc Natl Acad Sci USA 2000, 97:5895-5900.
94. Rodrigues-Lima F., Josephs M., Katan M., Cassinat B. Sequence analysis identifies TTRAP, a protein that associates with CD40 and TNF receptor-associated factors, as a member of a superfamily of divalent cation-dependent phosphodiesterases. Biochem Biophys Res Commun 2001, 285:1274-1279.
95. Pei H., Yordy J.S., Leng Q., Zhao Q., Watson D.K., Li R. EAPII interacts with ETS1 and modulates its transcriptional function. Oncogene 2003, 22:2699-2709.
96. Hecker C.M., Rabiller M., Haglund K., Bayer P., Dikic I. Specification of SUMO1- and SUMO2-interacting motifs. J Biol Chem 2006, 281:16117-16127.
97. Zhang J.Q., Wang J.J., Li W.J., Huang L., Tian L., Xue J.L., et al. Cellular protein TTRAP interacts with HIV-1 integrase to facilitate viral integration. Biochem Biophys Res Commun 2009, 387:256-260.
98. Zucchelli S., Vilotti S., Calligaris R., Lavina Z.S., Biagioli M., Foti R., et al. Aggresome-forming TTRAP mediates pro-apoptotic properties of Parkinson's disease-associated DJ-1 missense mutations. Cell Death Differ 2009, 16:428-438.
99. Xu G.L., Pan Y.K., Wang B.Y., Huang L., Tian L., Xue J.L., et al. TTRAP is a novel PML nuclear bodies-associated protein. Biochem Biophys Res Commun 2008, 375:395-398.
100. Cortes Ledesma F., El Khamisy S.F., Zuma M.C., Osborn K., Caldecott K.W. A human 5'-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage. Nature 2009, 461:674-678.
101. Zeng Z., Cortés-Ledesma F., El Khamisy S.F., Caldecott K.W. TDP2/TTRAP is the major 5'-tyrosyl DNA phosphodiesterase activity in vertebrate cells and is critical for cellular resistance to topoisomerase II-induced DNA damage. J Biol Chem 2011, 286:403-409.
102. El-Khamisy S.F., Saifi G.M., Weinfeld M., Johansson F., Helleday T., Lupski J.R., et al. Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1. Nature 2005, 434:108-113.
103. Hirano R., Interthal H., Huang C., Nakamura T., Deguchi K., Choi K., et al. Spinocerebellar ataxia with axonal neuropathy: consequence of a Tdp1 recessive neomorphic mutation?. EMBO J 2007, 26:4732-4743.
104. Verschueren K., Remacle J.E., Collart C., Kraft H., Baker B.S., Tylzanowski P., et al. SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5'-CACCT sequences in candidate target genes. J Biol Chem 1999, 274:20489-20498.
105. Remacle J.E., Kraft H., Lerchner W., Wuytens G., Collart C., Verschueren K., et al. New mode of DNA binding of multi-zinc finger transcription factors: deltaEF1 family members bind with two hands to two target sites. EMBO J 1999, 18:5073-5084.
106. van Grunsven L.A., Taelman V., Michiels C., Verstappen G., Souopgui J., Nichane M., et al. XSip1 neuralizing activity involves the co-repressor CtBP and occurs through BMP dependent and independent mechanisms. Dev Biol 2007, 306:34-49.
107. Verstappen G., van Grunsven L.A., Michiels C., Van de Putte T., Souopgui J., Van Damme J., et al. Atypical Mowat-Wilson patient confirms the importance of the novel association between ZFHX1B/SIP1 and NuRD corepressor complex. Hum Mol Genet 2008, 17:1175-1183.
108. van Grunsven L.A., Taelman V., Michiels C., Opdecamp K., Huylebroeck D., Bellefroid E.J. deltaEF1 and SIP1 are differentially expressed and have overlapping activities during Xenopus embryogenesis. Dev Dyn 2006, 235:1491-1500.
109. Bracken C.P., Gregory P.A., Kolesnikoff N., Bert A.G., Wang J., Shannon M.F., et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 2008, 68:7846-7854.
110. Park S.M., Gaur A.B., Lengyel E., Peter M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008, 22:894-907. Erratum in: Genes Dev 2009;23:1378.
111. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008, 10:593-601.
112. Christoffersen N.R., Silahtaroglu A., Orom U.A., Kauppinen S. Lund AH. miR-200b mediates post-transcriptional repression of ZFHX1B. RNA 2007, 13:1172-1178.
113. Wakamatsu N., Yamada Y., Yamada K., Ono T., Nomura N., Taniguchi H., et al. Mutations in SIP1, encoding Smad interacting protein-1, cause a form of Hirschsprung disease. Nat Genet 2001, 27:369-370.
114. Cacheux V., Dastot-Le Moal F., Kääriäinen H., Bondurand N., Rintala R., Boissier B., et al. Loss-of-function mutations in SIP1 Smad interacting protein 1 result in a syndromic Hirschsprung disease. Hum Mol Genet 2001, 10:1503-1510.
115. Zweier C., Thiel C.T., Dufke A., Crow Y.J., Meinecke P., Suri M., et al. Clinical and mutational spectrum of Mowat-Wilson syndrome. Eur J Med Genet 2005, 48:97-111.
116. Dastot-Le Moal F., Wilson M., Mowat D., Collot N., Niel F., Goossens M. ZFHX1B mutations in patients with Mowat-Wilson syndrome. Hum Mutat 2007, 28:313-321.
117. Garavelli L., Zollino M., Mainardi P.C., Gurrieri F., Rivieri F., Soli F., et al. Mowat-Wilson syndrome: facial phenotype changing with age: study of 19 Italian patients and review of the literature. Am J Med Genet A 2009, 149A:417-426.
118. Saunders C.J., Zhao W., Ardinger H.H. Comprehensive ZEB2 gene analysis for Mowat-Wilson syndrome in a North American cohort: a suggested approach to molecular diagnostics. Am J Med Genet A 2009, 149A:2527-2531.
119. Adam M.P., Schelley S., Gallagher R., Brady A.N., Barr K., Blumberg B., et al. Clinical features and management issues in Mowat-Wilson syndrome. Am J Med Genet A 2006, 140:2730-2741.
120. Van de Putte T., Maruhashi M., Francis A., Nelles L., Kondoh H., Huylebroeck D., et al. Mice lacking ZFHX1B, the gene that codes for Smad-interacting protein-1, reveal a role for multiple neural crest cell defects in the etiology of Hirschsprung disease-mental retardation syndrome. Am J Hum Genet 2003, 72:465-470.
121. Van de Putte T., Francis A., Nelles L., van Grunsven L.A., Huylebroeck D. Neural crest-specific removal of Zfhx1b in mouse leads to a wide range of neurocristopathies reminiscent of Mowat-Wilson syndrome. Hum Mol Genet 2007, 16:1423-1436.
122. Maruhashi M., Van De Putte T., Huylebroeck D., Kondoh H., Higashi Y. Involvement of SIP1 in positioning of somite boundaries in the mouse embryo. Dev Dyn 2005, 234:332-338.
123. Jeub M., Emrich M., Pradier B., Taha O., Gailus-Durner V., Fuchs H., et al. The transcription factor Smad-interacting protein 1 controls pain sensitivity via modulation of DRG neuron excitability. Pain 2011, 152:2384-2398.
124. Seuntjens E., Nityanandam A., Miquelajauregui A., Debruyn J., Stryjewska A., Goebbels S., et al. Sip1 regulates sequential fate decisions by feedback signaling from postmitotic neurons to progenitors. Nat Neurosci 2009, 12:1373-1380.
125. Chng Z., Teo A., Pedersen R.A., Vallier L. SIP1 mediates cell-fate decisions between neuroectoderm and mesendoderm in human pluripotent stem cells. Cell Stem Cell 2010, 6:59-70.
126. Goossens S., Janzen V., Bartunkova S., Yokomizo T., Drogat B., Crisan M., et al. The EMT regulator Zeb2/Sip1 is essential for murine embryonic haematopoietic stem/progenitor cell differentiation and mobilization. Blood 2011, 117:5620-5630.
127. Huang S., Tang B., Usoskin D., Lechleider R.J., Jamin S.P., Li C., et al. Conditional knockout of the Smad1 gene. Genesis 2002, 32(2 (February)):76-79.
128. Umans L., Vermeire L., Francis A., Chang H., Huylebroeck D., Zwijsen A. Generation of a floxed allele of Smad5 for cre-mediated conditional knockout in the mouse. Genesis 2003, 37(1 (September)):5-11.
129. Hester M., Thompson J.C., Mills J., Liu Y., El-Hodiri H.M., Weinstein M. Smad1 and Smad8 function similarly in mammalian central nervous system development. Mol Cell Biol 2005, 25(11 (June)):4683-4692.
130. Huang J., Dattilo L.K., Rajagopal R., Liu Y., Kaartinen V., Mishina Y., et al. FGF-regulated BMP signaling is required for eyelid closure and to specify conjunctival epithelial cell fate. Development 2009, 136:1741-1750.
131. Yang S.M., Guo W.W., Hu Y.Y., Sun Y.X., Hou Z.H., Sun J.H., et al. Smad5 haploinsufficiency leads to hair cell and hearing loss. Dermatol Nurs 2009, 69:153-161.
132. Allaire J.M., Darsigny M., Marcoux S.S., Roy S.A., Schmouth J.F., Umans L., et al. Loss of Smad5 leads to the disassembly of the apical junctional complex and increased susceptibility to experimental colitis. Am J Physiol Gastrointest Liver Physiol 2011, 300:G586-G597.
133. Singbrant S., Karlsson G., Ehinger M., Olsson K., Jaako P., Miharada K., et al. Canonical BMP signaling is dispensable for haematopoietic stem cell function in both adult and fetal liver haematopoiesis, but essential to preserve colon architecture. Blood 2010, 115:4689-4698.
134. Rajagopal R., Dattilo L.K., Kaartinen V., Deng C.X., Umans L., Zwijsen A., et al. Functions of the type 1 BMP receptor Acvr1 (Alk2) in lens development: cell proliferation, terminal differentiation, and survival. Invest Ophthalmol Vis Sci 2008, 49:4953-4960.
135. Rajagopal R., Huang J., Dattilo L.K., Kaartinen V., Mishina Y., Deng C.X., et al. The type I BMP receptors Bmpr1a and Acvr1, activate multiple signaling pathways to regulate lens formation. Dev Biol 2009, 335:305-316.
136. Singbrant S., Moody J.L., Blank U., Karlsson G., Umans L., Zwijsen A., et al. Smad5 is dispensable for adult murine haematopoiesis. Blood 2006, 108:3707-3712.
137. Xu B., Chen C., Chen H., Zheng S.G., Bringas P., Xu M., et al. Smad1 and its target gene Wif1 coordinate BMP and Wnt signaling activities to regulate fetal lung development. Development 2011, 138:925-935.
138. Retting K.N., Song B., Yoon B.S., Lyons K.M. BMP canonical Smad signaling through Smad1 and Smad5 is required for endochondral bone formation. Development 2009, 136:1093-1104.
139. Wang M., Jin H., Tang D., Huang S., Zuscik M.J., Chen D. Smad1 plays an essential role in bone development and postnatal bone formation. Osteoarthritis Cartilage 2011, 19:751-762.
140. Higashi Y., Maruhashi M., Nelles L., Van de Putte T., Verschueren K., Miyoshi T., et al. Generation of the floxed allele of the SIP1 (Smad-interacting protein 1) gene for Cre-mediated conditional knockout in the mouse. Genesis 2002, 32:82-84.
141. Stanchina L., Van de Putte T., Goossens M., Huylebroeck D., Bondurand N. Genetic interaction between Sox10 and Zfhx1b during enteric nervous system development. Dev Biol 2010, 341:416-428.
142. Miyoshi T., Maruhashi M., Van De Putte T., Kondoh H., Huylebroeck D., Higashi Y. Complementary expression pattern of Zfhx1 genes Sip1 and deltaEF1 in the mouse embryo and their genetic interaction revealed by compound mutants. Dev Dyn 2006, 235:1941-1952.
143. Yoshimoto A., Saigou Y., Higashi Y., Kondoh H. Regulation of ocular lens development by Smad-interacting protein 1 involving Foxe3 activation. Development 2005, 132:4437-4448.
144. Miquelajauregui A., Van de Putte T., Polyakov A., Nityanandam A., Boppana S., Seuntjens E., et al. Smad-interacting protein-1 (Zfhx1b) acts upstream of Wnt signaling in the mouse hippocampus and controls its formation. Proc Natl Acad Sci USA 2007, 104:12919-12924.
145. Phng L.K., Gerhardt H. Angiogenesis: a team effort coordinated by Notch. Dev Cell 2009, 16:196-208.
146. Ryan K., Calvo O., Manley J.L. Evidence that polyadenylation factor CPSF-73 is the mRNA 3' processing endonuclease. RNA 2004, 10:565-573.
147. Tomecki R., Dziembowski A. Novel endoribonucleases as central players in various pathways of eukaryotic RNA metabolism. RNA 2010, 16:1692-1724.
148. Long J., Zuo D., Park M. Pc2-mediated sumoylation of Smad-interacting protein 1 attenuates transcriptional repression of E-cadherin. J Biol Chem 2005, 280:35477-35489.
149. van Grunsven L.A., Michiels C., Van de Putte T., Nelles L., Wuytens G., Verschueren K., et al. Interaction between Smad-interacting protein-1 and the corepressor C-terminal binding protein is dispensable for transcriptional repression of E-cadherin. J Biol Chem 2003, 278:26135-26145.
150. Comijn J., Berx G., Vermassen P., Verschueren K., van Grunsven L., Bruyneel E., et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001, 7:1267-1278.
151. Postigo A.A., Depp J.L., Taylor J.J., Kroll K.L. Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins. EMBO J 2003, 22:2453-2462.